LH monthly performance report
View LH's monthly returns, drawdown, and seasonality trends — updated every month.
LH monthly report
—
Key takeaways
- LabCorp (LH) closed November 2026 at $372.32, up 3.02% for the month and +39.97% over the trailing 12 months.
- Year-to-date, LH is +48.41%, outperforming the S&P 500 which has returned +11.03% YTD.
- The stock is trading +27.53% versus its 200-day moving average ($291.95), a bullish technical signal.
- Over the past three years, LH has outperformed the S&P 500 by +9.98%, with a relative strength index reading of 105.9.
- Win rate over the trailing 39 months stands at 61.5% — 24 positive months versus 15 negative months.
LabCorp ended November 2026 at $372.32, posting a monthly return of +3.02%. The S&P 500 returned +0.19% over the same window, leaving relative performance at +2.84%.
The current quarter stands at +20.84% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +27.53% versus the 200-day moving average ($291.95).
Year-to-date, LH is +48.41% against SPY +11.03%, a gap of +37.38%. The stock is currently −0.74% below its 52-week high, with maximum 3-year drawdown at −17.36%.
| Period | LH | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.02% | −0.35% | +0.38% |
| 1 Week | +2.48% | +3.29% | −0.81% |
| 1 Month | +3.02% | +0.19% | +2.84% |
| 3 Months | +17.03% | −2.48% | +19.51% |
| 6 Months | +46.34% | +2.00% | +44.35% |
| YTD | +48.41% | +11.03% | +37.38% |
| 12 Months | +39.97% | +10.79% | +29.18% |
| 3 Years | +81.81% | +71.83% | +9.98% |
| Rank | Month | Return |
|---|---|---|
| #1 | Oct 2026 | +17.29% |
| #2 | Jul 2026 | +10.43% |
| #3 | Jan 2025 | +8.93% |
| #4 | Nov 2023 | +8.60% |
| #5 | Jan 2026 | +8.23% |
| Rank | Month | Return |
|---|---|---|
| #1 | Oct 2025 | −11.53% |
| #2 | Apr 2024 | −7.82% |
| #3 | Mar 2026 | −7.72% |
| #4 | Sep 2026 | −7.38% |
| #5 | Mar 2025 | −7.29% |
| Quarter | Return |
|---|---|
| Q3 2025 | +9.35% |
| Q4 2025 | −12.60% |
| Q1 2026 | +6.35% |
| Q2 2026 | +4.94% |
| Q3 2026 | +10.04% |
| Q4 2026 (QTD) | +20.84% |
| Year | Return |
|---|---|
| 2023 | +12.35% |
| 2024 | +0.89% |
| 2025 | +9.40% |
| 2026 | +48.41% |
| Metric | Value |
|---|---|
| 52-Week High | $375.10 (2026-11-12) |
| 52-Week Low | $245.00 (2026-01-05) |
| Current Price | $372.32 |
| 200-Day Moving Average | $291.95 |
| Price vs 200DMA | +27.53% |
| 3-Year Maximum Drawdown | −17.36% (2025-04-21) |
| Current Drawdown from 52W High | −0.74% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 105.9 |
| 3-Year Excess Return vs S&P 500 | +9.98% |
| RS Peak | 107.4 (Nov 2026) |
| RS Trough | 72.9 (Jun 2026) |
| Status | Outperforming Benchmark |
Frequently asked questions
What was LH's return for this report period?
LH returned +3.02% in the latest monthly window ending 2026-11-12.
Has LH outperformed SPY year to date?
YTD LH: +48.41% vs SPY: +11.03%.
What is LH's 12-month return?
+39.97% over the trailing 12 months.
Is LH above or below its 200-day moving average?
Price is +27.53% versus 200DMA ($291.95).
What is the maximum drawdown in the 3-year window?
−17.36% on 2025-04-21.